Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Bruce Neal, Ngozi Erondu et al.|The Lancet Diabetes & Endocrinology|2018Cited by 642
Characterization of a Robust Enzymatic Assay for Inhibitors of 2-Oxoglutarate-Dependent HydroxylasesKimon C. Kanelakis, Terrance D. Barrett, Heather L. Palomino et al.|SLAS DISCOVERY|2009Cited by 14